The Urban Environment and Childhood Asthma study
- PMID: 20226291
- PMCID: PMC2860857
- DOI: 10.1016/j.jaci.2010.01.037
The Urban Environment and Childhood Asthma study
Abstract
Childhood asthma is not distributed evenly throughout the population, and children who grow up in crowded urban neighborhoods have higher rates of asthma and experience greater morbidity because of asthma. There are several environmental and lifestyle factors associated with urban living that are suspected to promote the development of asthma, particularly in the first few years of life. Collectively, this information suggests the hypothesis that exposure in early life to adverse environmental and lifestyle factors associated with disadvantaged urban environments modifies immune development to increase the risk for allergic diseases and asthma. The Urban Environment and Childhood Asthma (URECA) birth cohort study was initiated in 2004 to test this hypothesis. The study population was recruited prenatally and consisted of 560 families from 4 urban areas who were at high risk for allergies and/or asthma on the basis of parental histories, along with an additional 49 families without atopic parents. Immune development, respiratory illnesses, and exposure to stress, indoor pollutants, microbial products, and allergens were measured prospectively, and the major study outcomes are recurrent wheeze at 3 years of age and asthma at age 7 years. This review summarizes the study design, methods, and early findings of the URECA study.
Figures


References
-
- von Mutius E. Allergies, infections and the hygiene hypothesis--the epidemiological evidence. Immunobiology. 2007;212(6):433–9. - PubMed
-
- Prescott SL. Early origins of allergic disease: a review of processes and influences during early immune development. Current Opinion in Allergy & Clinical Immunology. 2003;3(2):125–32. - PubMed
-
- Lucas SR, Platts-Mills TA. Physical activity and exercise in asthma: relevance to etiology and treatment. J Allergy Clin Immunol. 2005;115(5):928–34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-AI-25482/AI/NIAID NIH HHS/United States
- N01 AI025496/AI/NIAID NIH HHS/United States
- UL1 RR024992/RR/NCRR NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- RR00052/RR/NCRR NIH HHS/United States
- UL1 TR000448/TR/NCATS NIH HHS/United States
- M01RR00071/RR/NCRR NIH HHS/United States
- 1UL1RR024156/RR/NCRR NIH HHS/United States
- HHSN272200900052C/AI/NIAID NIH HHS/United States
- N01-AI-25496/AI/NIAID NIH HHS/United States
- 5UL1RR024992-02/RR/NCRR NIH HHS/United States
- M01RR00533/RR/NCRR NIH HHS/United States
- N01 AI025482/AI/NIAID NIH HHS/United States
- M01 RR000533/RR/NCRR NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- UL1 RR025771/RR/NCRR NIH HHS/United States
- M01 RR000052/RR/NCRR NIH HHS/United States
- 1UL1RR025771/RR/NCRR NIH HHS/United States